GAIL (India) Ltd Q1 FY27 Results Analysis: PAT Jumps 127.6%, EBITDA Margin Expands 630 bps

CompoundingAI Research Updated July 31, 2026 2 min read
Positive

GAIL (India) Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 38,981.63 Cr (+12.00% YoY) and PAT growth of +127.60% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 31, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 38,981.63 Cr (+12.00% YoY)
PAT (Q1)Rs. 4,292.33 Cr (+127.60% YoY)
EBITDA margin16.40% (+630 bps YoY)
EPS (Q1)Rs. 6.53 (+127.50% YoY)
Market capRs. 119,360.47 Cr
CMPRs. 181.44

Quarter Snapshot

GAIL reported strong Q1 FY27 results with PAT up 127.6% YoY and EBITDA margin expanding 630 bps, driven by operating leverage and a sharp recovery in Natural Gas Marketing. Positive catalysts include regulatory tariff hikes and APM gas allocation, but headwinds from LNG supply disruptions and a rising debt-equity ratio temper the outlook.

Key Investment Insights

Key Positives

  • PAT grew 127.6% YoY to Rs.4,292 crore.
  • EBITDA margin expanded 630 bps YoY to 16.4%.
  • Natural Gas Marketing segment EBIT surged 224.9% YoY to Rs.3,481 crore, recovering from a loss in Q4.
  • LPG & Liquid Hydrocarbons EBIT rose 276.8% YoY to Rs.773 crore.
  • Revenue grew 12.0% YoY to Rs.38,982 crore.
  • Operating expenses grew only 3.8% YoY, demonstrating operating leverage.

Risk Factors

  • LNG supply disruptions from West Asia impacted seven cargoes; mitigation through spot procurement.
  • Finance costs increased 47.9% YoY due to higher borrowings.
  • Petrochemicals segment remained loss-making at Rs.123 crore loss (though narrowed from Rs.249 Cr).
  • Debt-equity ratio rose to 0.32x from 0.24x YoY.
  • Contingent liability of Rs.3,799 crore on naphtha classification dispute.
  • No independent directors on board since March 2026.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now